Enhancement of peritoneal leukocyte function by granulocyte colony-stimulating factor in rats with abdominal sepsis.

OBJECTIVE To investigate the therapeutic effects of granulocyte colony-stimulating factor (G-CSF) on the functional activities of circulating and peritoneal neutrophils during intra-abdominal sepsis. DESIGN Placebo, controlled study, using a rat model of intra-abdominal sepsis. SETTING Animal research facility. SUBJECTS Male specific pathogen-free Sprague-Dawley rats. INTERVENTIONS Abdominal sepsis was produced in rats by cecal ligation and puncture. The control animals received a sham operation. G-CSF (subcutaneous injection at 50 microg/kg) or vehicle (100 microL of 5% dextrose) treatment was initiated at 1 hr after cecal ligation and puncture or sham operation and repeated at 12-hr intervals thereafter. MEASUREMENTS AND MAIN RESULTS Six hours after cecal ligation and puncture, CD11b/c and CD18 expression on circulating neutrophils was significantly up-regulated when compared with those in the sham operated control animals. Peritoneal neutrophils exhibited a further up-regulation of these adhesion molecules than did the circulating neutrophils. A sustained up-regulation of CD11b/c and CD18 was found in peritoneal neutrophils even at 24 hrs after cecal ligation and puncture. G-CSF treatment increased CD11b/c expression on circulating neutrophils in 6-hr sham-operated rats, but did not further up-regulate CD11b/c or CD18 expression on circulating or peritoneal neutrophils in cecal ligation and puncture rats. Phagocytic activities of circulating neutrophils assessed by uptake of fluorescent latex microspheres were lower in 24-hr cecal ligation and puncture rats when compared with the sham-operated controls. G-CSF treatment prevented this inhibition. Furthermore, G-CSF enhanced the phagocytic activities of peritoneal neutrophils in both 6- and 24-hr cecal ligation and puncture rats when compared with those of the vehicle-treated animals. Spontaneous hydrogen peroxide generation by circulating neutrophils was increased in 6-hr cecal ligation and puncture rats, but not in 24-hr cecal ligation and puncture rats. Peritoneal neutrophils exhibited an inhibition of phorbol myristate acetate-stimulated hydrogen peroxide generation. G-CSF treatment did not up-regulate neutrophil hydrogen peroxide generation. CONCLUSIONS Circulating and peritoneal neutrophils exhibit marked polymorphism in their functional activities during the host response to abdominal sepsis. G-CSF treatment significantly enhanced the phagocytic function of both circulating and peritoneal neutrophils which may be one mechanism underlying its protective effect in abdominal sepsis.

[1]  G. Bagby,et al.  MODULATION OF THE LUNG HOST RESPONSE BY GRANULOCYTE COLONY‐STIMULATING FACTOR IN RATS CHALLENGED WITH INTRAPULMONARY ENDOTOXIN , 1997, Shock.

[2]  Ping Zhang,et al.  PROTEIN TYROSINE KINASE ACTIVITY AND THE INFLUENCE OF GENDER IN PHAGOCYTOSIS AND TUMOR NECROSIS FACTOR SECRETION IN ALVEOLAR MACROPHAGES AND LUNG‐RECRUITED NEUTROPHILS , 1996, Shock.

[3]  T. Shimazu,et al.  Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis. , 1996, The Journal of trauma.

[4]  J. Nesland,et al.  Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats. , 1996, Critical care medicine.

[5]  J. White,et al.  Effects of granulocyte colony stimulating factor in a nonneutropenic rodent model of Escherichia coli peritonitis. , 1996, The Journal of surgical research.

[6]  Ping Zhang,et al.  ATTENUATION OF HEPATIC NEUTROPHIL SEQUESTRATION BY ANTI‐CINC ANTIBODY IN ENDOTOXIC RATS , 1995, Shock.

[7]  P. Wernet,et al.  Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients. , 1995, Journal of critical care.

[8]  E. Lingaas,et al.  Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intra-abdominal sepsis in rats. , 1995, Shock.

[9]  J. A. Spitzer,et al.  Generation of a CD11b/c upregulating and chemotactic factor by hepatocytes of endotoxic rats--nonidentity with interleukin-8. , 1994, Shock.

[10]  L. Elfman,et al.  Serum levels of granulocyte‐colony stimulating factor (G‐CSF) in bacterial and viral infections, and in atypical pneumonia , 1994, British journal of haematology.

[11]  Ping Zhang,et al.  HEPATIC NEUTROPHIL SEQUESTRATION IN EARLY SEPSIS: ENHANCED EXPRESSION OF ADHESION MOLECULES AND PHAGOCYTIC ACTIVITY , 1994, Shock.

[12]  J. A. Spitzer,et al.  Functional characterization of peripheral circulating and liver recruited neutrophils in endotoxic rats , 1994, Journal of leukocyte biology.

[13]  J. Cebon,et al.  Endogenous haemopoietic growth factors in neutropenia and infection , 1994, British journal of haematology.

[14]  T. Yoshida,et al.  Effects of granulocyte colony stimulating factor and monobactam antibiotics (Aztreonam) on neutrophil functions in sepsis. , 1993, Clinical immunology and immunopathology.

[15]  G. Mandell,et al.  The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity. , 1993, Blood.

[16]  D. Linch,et al.  Differential effects of granulocyte‐ and granulocyte‐macrophage colony‐stimulating factors (G‐ and GM‐CSF) on neutrophil adhesion in vitro and in vivo , 1992, European journal of haematology.

[17]  M. Krangel,et al.  Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. , 1992, Critical reviews in immunology.

[18]  T. Dexter,et al.  Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. , 1991, Blood.

[19]  T J Walsh,et al.  Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. , 1991, The Journal of infectious diseases.

[20]  J. Harlan,et al.  Transient inhibition of neutrophil adherence with the anti-CD18 monoclonal antibody 60.3 does not increase mortality rates in abdominal sepsis. , 1991, Surgery.

[21]  T. Kumakawa,et al.  Levels of serum granulocyte colony-stimulating factor in patients with infections. , 1990, Blood.

[22]  A Howell,et al.  The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Scadden,et al.  Hematopoietic growth factors. Biology and clinical applications. , 1989, The New England journal of medicine.

[24]  R. Kamen,et al.  The human hematopoietic colony-stimulating factors. , 1987, Science.

[25]  J. Gabrilove,et al.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. , 1986, Science.

[26]  S. Taniuchi,et al.  A quantitative assay of oxidative metabolism by neutrophils in whole blood using flow cytometry. , 1985, Journal of immunological methods.

[27]  I. Chaudry,et al.  Sepsis and septic shock--a review of laboratory models and a proposal. , 1980, The Journal of surgical research.